| Literature DB >> 22029703 |
Bożena Wiskirska-Woźnica1, Małgorzata Leszczyńska, Hanna Czerniejewska, Joanna Jackowska, Szyfter Witold.
Abstract
BACKGROUND: Treatment of laryngeal cancers, may include surgery, radiotherapy, chemotherapy, or a combination. Total laryngectomy (TL) has been the standard surgical treatment. Partial laryngectomy procedures were performed, their advantage over TL is preservation of laryngeal functions.Entities:
Mesh:
Year: 2011 PMID: 22029703 PMCID: PMC3224752 DOI: 10.1186/1758-3284-3-46
Source DB: PubMed Journal: Head Neck Oncol ISSN: 1758-3284
Figure 1Supracricoid laryngectomy with CHP.
Figure 2Supracricoid laryngectomy with CHEP.
Figure 3Transglottic laryngectomy according to Calearo.
Figure 4Transglottic laryngectomy according to Sedlaček-Tucker.
Parameters and rates used in the voice evaluation
| Patient number | MPT (sec) | GRBAS scale | VHI score |
|---|---|---|---|
| 1/CHEP | 6 | G2R2B1A1S2 | 41 |
| 2/Calero | 5 | G2R2B1A1S1 | 16 |
| 3/CHEP | 8 | G3R3B2A1S3 | 17 |
| 4/Supraglottic | 7 | G1R1B0A0S0 | 11 |
| 5/Calearo | 8 | G2R3B2A1S2 | 48 |
| 6/Calearo | 4 | G2R3B1A1S2 | 67 |
| 7/Calearo | 18 | G3R2B1A0S1 | 17 |
| 8/Sedlacek | 6 | G2R1B2A1S2 | 22 |
| 9/Calearo | 5 | G3R2B2A1S2 | 32 |
| 10/Sedlacek | 17 | G2R1B1A0S2 | 11 |
| 11/Supraglottic | 9 | G2R1B0A0S1 | 17 |
| 12/CHEP | 2 | G3R2B1A0S2 | 104 |
| 13/Calearo | 21 | G2R1B0A1S2 | 15 |
| 14/Calearo | 7 | G3R2B1A2S2 | 5 |
| 15/CHEP | 14 | G2R2B1A1S2 | 23 |
| 16/Calearo | 6 | G2R0B2A1S1 | 26 |
| 17/Calearo | 5 | G1R0B0A0S1 | 19 |
| 18/Calearo | 8 | G3R2B2A2S0 | 52 |
| 19/Sedlacek | 4 | G3R3B3A2S2 | 49 |
| 20/Calearo | 14 | G1R1B1A0S1 | 43 |
Types of neoglottis in our group of patients after partial laryngectomy
| Types of neoglottis and phonation closure | Number of cases |
|---|---|
| One vocal fold and epiglottis | 7 |
| Laryngeal surface of epiglottis, 2 arytenoid cartilages and 2 pseudo-folds | 7 |
| Laryngeal surface of epiglottis and 2 arytenoid cartilages | 1 |
| Scar after epiglittis and 2 aryepiglottic folds | 2 |
| Pseudo vocal folds | 1 |
| Pseudo- folds without arytenoid cartilages | 2 |
Figure 5Neoglottis - after Calearo method surgery.
Figure 6Neoglottis - after CHEP.
Figure 7Neoglottis - after laryngectomy by the Sedlacek method.
The relevance of differences between the acoustic results of the various types of operation in comparison to norms (Mann-Whitney test)
| CALEARO | CHEP | p | CHEP | SEDL | p | CALEARO | SEDL | p | Pathology | Norm | p | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STD | 7 | 4 | 0.5273 | 4 | 3 | 1 | 7 | 3 | 0.8571 | 14 | 61 | |
| JITA | 7 | 4 | 0.5273 | 4 | 3 | 0.1833 | 7 | 3 | 0.8571 | 14 | 61 | |
| JITT | 7 | 4 | 0.2303 | 4 | 3 | 0.1833 | 7 | 3 | 0.6286 | 14 | 61 | |
| RAP | 7 | 4 | 0.9273 | 4 | 3 | 0.1167 | 7 | 3 | 0.2286 | 14 | 61 | |
| PPQ | 7 | 4 | 0.2303 | 4 | 3 | 0.3833 | 7 | 3 | 0.6286 | 14 | 61 | |
| SPPQ | 7 | 4 | 0.3152 | 4 | 3 | 0.2667 | 7 | 3 | 0.6286 | 14 | 61 | |
| VFO | 7 | 4 | 0.6485 | 4 | 3 | 0.6667 | 7 | 3 | 0.2286 | 14 | 61 | |
| SHDB | 7 | 4 | 4 | 3 | 7 | 3 | 0.8571 | 14 | 61 | |||
| SHIM | 7 | 4 | 4 | 3 | 7 | 3 | 0.8571 | 14 | 61 | |||
| APQ | 7 | 4 | 0.0727 | 4 | 3 | 7 | 3 | 0.6286 | 14 | 61 | ||
| SAPQ | 7 | 4 | 0.2303 | 4 | 3 | 0.0667 | 7 | 3 | 1.1429 | 14 | 61 | |
| VAM | 7 | 4 | 0.6485 | 4 | 3 | 0.5167 | 7 | 3 | 0.8571 | 14 | 61 | |
| NHR | 7 | 4 | 0.3152 | 4 | 3 | 0.1167 | 7 | 3 | 0.8571 | 14 | 61 | |
| VTI | 7 | 4 | 0.6485 | 4 | 3 | 0.1833 | 7 | 3 | 0.4 | 14 | 61 | |
| SPI | 7 | 4 | 0.7879 | 4 | 3 | 0.1167 | 7 | 3 | 0.4 | 14 | 61 | |
| DVB | 7 | 4 | 0.1091 | 4 | 3 | 0.3833 | 7 | 3 | 0.1143 | 14 | 61 | |
| DSH | 7 | 4 | 0.1636 | 4 | 3 | 0.5167 | 7 | 3 | 0.2286 | 14 | 61 | |
| DUV | 7 | 4 | 0.3152 | 4 | 3 | 0.2667 | 7 | 3 | 0.4 | 14 | 61 | |
| NVB | 7 | 4 | 0.3152 | 4 | 3 | 0.3833 | 7 | 3 | 0.1143 | 14 | 61 | |
| NSH | 7 | 4 | 0.1636 | 4 | 3 | 0.6667 | 7 | 3 | 0.2286 | 14 | 61 | |
| NUV | 7 | 4 | 0.3152 | 4 | 3 | 0.3833 | 7 | 3 | 0.8571 | 14 | 61 | |
Figure 8Comparison of mean values of Jitt, Shim, NHR and standard deviation between groups: norm/patol., Cal/CHEP, CAL/Sedl., CHEP/Sedl.